+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Mens Health Diagnostics Market Research Report by Product Type, Type or Indication, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 220 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 5533359
UP TO OFF until Dec 31st 2022
The Global Mens Health Diagnostics Market size was estimated at USD 10.74 billion in 2021, USD 11.89 billion in 2022, and is projected to grow at a CAGR of 10.89% to reach USD 19.99 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Mens Health Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product Type, the market was studied across Blood Test, Electrocardiogram, MRI of the Prostate, Testosterone Levels Test, Ultrasound Test, Ultrasound-Guided Prostate Biopsy, Urethrogram, Urine Tests, and X-Ray.
  • Based on Type or Indication, the market was studied across Colorectal Cancer, Erectile Dysfunction, Prostate Cancer, and Testicular cancer.
  • Based on End-user, the market was studied across Diagnostic Laboratories, Hospitals & Ambulatory Surgery Center, and Research & Academic Institutes.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Mens Health Diagnostics market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Mens Health Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Mens Health Diagnostics Market, including Access Pharmaceuticals, Inc., Advanz Pharma, ASKA Pharmaceutical Co., Aurobindo Pharma, Boston Scientific, CordexPharma, Inc., Eli Lilly and Company, Intas Pharmaceuticals Ltd., Pantarhei Bioscience BV, Pfizer, Teva Pharmaceuticals, Trophogen, Inc., and ZydusCadila Healthcare Ltd..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Mens Health Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Mens Health Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Mens Health Diagnostics Market?
4. What is the competitive strategic window for opportunities in the Global Mens Health Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global Mens Health Diagnostics Market?
6. What is the market share of the leading vendors in the Global Mens Health Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the Global Mens Health Diagnostics Market?
Frequently Asked Questions about the Global Mens Health Diagnostics Market

What is the estimated value of the Global Mens Health Diagnostics Market?

The Global Mens Health Diagnostics Market was estimated to be valued at $10.74 Billion in 2021.

What is the growth rate of the Global Mens Health Diagnostics Market?

The growth rate of the Global Mens Health Diagnostics Market is 10.8%, with an estimated value of $19.99 Billion by 2027.

What is the forecasted size of the Global Mens Health Diagnostics Market?

The Global Mens Health Diagnostics Market is estimated to be worth $19.99 Billion by 2027.

Who are the key companies in the Global Mens Health Diagnostics Market?

Key companies in the Global Mens Health Diagnostics Market include Access Pharmaceuticals, Inc., Advanz Pharma, ASKA Pharmaceutical Co., Aurobindo Pharma, Boston Scientific, CordexPharma, Inc., Eli Lilly and Company, Intas Pharmaceuticals Ltd. and Pfizer.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Widespread popularity of convenience food, junk food, and other unhealthy eating habits
5.1.1.2. Increased incidence of diseases caused by smoking such as emphysema among the western population
5.1.1.3. Adoption of home diagnostics kit
5.1.2. Restraints
5.1.2.1. Hesitation of seeking medical advice
5.1.3. Opportunities
5.1.3.1. Rising initiatives by the Government to strengthen the healthcare sector
5.1.3.2. Increasing public interest in healthcare, especially in urban cities
5.1.3.3. Increasing use of innovative technologies such as IoT and AI
5.1.4. Challenges
5.1.4.1. Stringent adherence to rules laid down by regulatory
5.2. Cumulative Impact of COVID-19
6. Mens Health Diagnostics Market, by Product Type
6.1. Introduction
6.2. Blood Test
6.3. Electrocardiogram
6.4. MRI of the Prostate
6.5. Testosterone Levels Test
6.6. Ultrasound Test
6.7. Ultrasound-Guided Prostate Biopsy
6.8. Urethrogram
6.9. Urine Tests
6.10. X-Ray
7. Mens Health Diagnostics Market, by Type or Indication
7.1. Introduction
7.2. Colorectal Cancer
7.3. Erectile Dysfunction
7.4. Prostate Cancer
7.5. Testicular cancer
8. Mens Health Diagnostics Market, by End-user
8.1. Introduction
8.2. Diagnostic Laboratories
8.3. Hospitals & Ambulatory Surgery Center
8.4. Research & Academic Institutes
9. Americas Mens Health Diagnostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Mens Health Diagnostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Mens Health Diagnostics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Access Pharmaceuticals, Inc.
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Advanz Pharma
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. ASKA Pharmaceutical Co.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Aurobindo Pharma
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Boston Scientific
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. CordexPharma, Inc.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Eli Lilly and Company
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Intas Pharmaceuticals Ltd.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Pantarhei Bioscience BV
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Pfizer
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Teva Pharmaceuticals
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Trophogen, Inc.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. ZydusCadila Healthcare Ltd.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL MENS HEALTH DIAGNOSTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 4. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. GLOBAL MENS HEALTH DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL MENS HEALTH DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL MENS HEALTH DIAGNOSTICS MARKET DYNAMICS
FIGURE 11. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL MENS HEALTH DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT TYPE, 2027
FIGURE 14. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2027 (USD BILLION)
FIGURE 15. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAM, 2018-2027 (USD BILLION)
FIGURE 16. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY MRI OF THE PROSTATE, 2018-2027 (USD BILLION)
FIGURE 17. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TESTOSTERONE LEVELS TEST, 2018-2027 (USD BILLION)
FIGURE 18. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TEST, 2018-2027 (USD BILLION)
FIGURE 19. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND-GUIDED PROSTATE BIOPSY, 2018-2027 (USD BILLION)
FIGURE 20. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY URETHROGRAM, 2018-2027 (USD BILLION)
FIGURE 21. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY URINE TESTS, 2018-2027 (USD BILLION)
FIGURE 22. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY X-RAY, 2018-2027 (USD BILLION)
FIGURE 23. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2021 VS 2027 (%)
FIGURE 24. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2021 VS 2027 (USD BILLION)
FIGURE 25. GLOBAL MENS HEALTH DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE OR INDICATION, 2027
FIGURE 26. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, 2018-2027 (USD BILLION)
FIGURE 27. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ERECTILE DYSFUNCTION, 2018-2027 (USD BILLION)
FIGURE 28. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, 2018-2027 (USD BILLION)
FIGURE 29. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TESTICULAR CANCER, 2018-2027 (USD BILLION)
FIGURE 30. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 31. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2021 VS 2027 (USD BILLION)
FIGURE 32. GLOBAL MENS HEALTH DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2027
FIGURE 33. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2027 (USD BILLION)
FIGURE 34. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS & AMBULATORY SURGERY CENTER, 2018-2027 (USD BILLION)
FIGURE 35. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, 2018-2027 (USD BILLION)
FIGURE 36. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 37. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 38. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 39. AMERICAS MENS HEALTH DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 40. ARGENTINA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 41. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 42. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 43. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 44. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 45. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 46. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 47. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 48. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 49. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 50. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 51. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 52. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 53. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 54. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 55. INDONESIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 56. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 57. MALAYSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 58. PHILIPPINES MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 59. SINGAPORE MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 60. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 61. TAIWAN MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 62. THAILAND MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 63. VIETNAM MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 68. DENMARK MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 69. EGYPT MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 70. FINLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 71. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 72. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 73. ISRAEL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 74. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 75. NETHERLANDS MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 76. NIGERIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 77. NORWAY MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 78. POLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 79. QATAR MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 80. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 81. SAUDI ARABIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 82. SOUTH AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 83. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 84. SWEDEN MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 85. SWITZERLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 86. TURKEY MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 87. UNITED ARAB EMIRATES MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 88. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 89. GLOBAL MENS HEALTH DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 90. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 91. GLOBAL MENS HEALTH DIAGNOSTICS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAM, 2018-2027 (USD BILLION)
TABLE 11. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2027 (USD BILLION)
TABLE 12. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2027 (USD BILLION)
TABLE 13. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY MRI OF THE PROSTATE, 2018-2027 (USD BILLION)
TABLE 14. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY MRI OF THE PROSTATE, BY REGION, 2018-2027 (USD BILLION)
TABLE 15. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY MRI OF THE PROSTATE, BY REGION, 2018-2027 (USD BILLION)
TABLE 16. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TESTOSTERONE LEVELS TEST, 2018-2027 (USD BILLION)
TABLE 17. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TESTOSTERONE LEVELS TEST, BY REGION, 2018-2027 (USD BILLION)
TABLE 18. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TESTOSTERONE LEVELS TEST, BY REGION, 2018-2027 (USD BILLION)
TABLE 19. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TEST, 2018-2027 (USD BILLION)
TABLE 20. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TEST, BY REGION, 2018-2027 (USD BILLION)
TABLE 21. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TEST, BY REGION, 2018-2027 (USD BILLION)
TABLE 22. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND-GUIDED PROSTATE BIOPSY, 2018-2027 (USD BILLION)
TABLE 23. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND-GUIDED PROSTATE BIOPSY, BY REGION, 2018-2027 (USD BILLION)
TABLE 24. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND-GUIDED PROSTATE BIOPSY, BY REGION, 2018-2027 (USD BILLION)
TABLE 25. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY URETHROGRAM, 2018-2027 (USD BILLION)
TABLE 26. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY URETHROGRAM, BY REGION, 2018-2027 (USD BILLION)
TABLE 27. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY URETHROGRAM, BY REGION, 2018-2027 (USD BILLION)
TABLE 28. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY URINE TESTS, 2018-2027 (USD BILLION)
TABLE 29. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY URINE TESTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 30. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY URINE TESTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 31. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY X-RAY, 2018-2027 (USD BILLION)
TABLE 32. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY X-RAY, BY REGION, 2018-2027 (USD BILLION)
TABLE 33. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY X-RAY, BY REGION, 2018-2027 (USD BILLION)
TABLE 34. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 35. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, 2018-2027 (USD BILLION)
TABLE 36. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2027 (USD BILLION)
TABLE 37. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2027 (USD BILLION)
TABLE 38. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ERECTILE DYSFUNCTION, 2018-2027 (USD BILLION)
TABLE 39. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ERECTILE DYSFUNCTION, BY REGION, 2018-2027 (USD BILLION)
TABLE 40. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ERECTILE DYSFUNCTION, BY REGION, 2018-2027 (USD BILLION)
TABLE 41. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, 2018-2027 (USD BILLION)
TABLE 42. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2027 (USD BILLION)
TABLE 43. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2027 (USD BILLION)
TABLE 44. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TESTICULAR CANCER, 2018-2027 (USD BILLION)
TABLE 45. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TESTICULAR CANCER, BY REGION, 2018-2027 (USD BILLION)
TABLE 46. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TESTICULAR CANCER, BY REGION, 2018-2027 (USD BILLION)
TABLE 47. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 48. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2027 (USD BILLION)
TABLE 49. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 50. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 51. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS & AMBULATORY SURGERY CENTER, 2018-2027 (USD BILLION)
TABLE 52. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS & AMBULATORY SURGERY CENTER, BY REGION, 2018-2027 (USD BILLION)
TABLE 53. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS & AMBULATORY SURGERY CENTER, BY REGION, 2018-2027 (USD BILLION)
TABLE 54. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, 2018-2027 (USD BILLION)
TABLE 55. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2027 (USD BILLION)
TABLE 56. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2027 (USD BILLION)
TABLE 57. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 58. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 59. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 60. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 61. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 62. ARGENTINA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 63. ARGENTINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 64. ARGENTINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 65. ARGENTINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 66. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 67. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 68. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 69. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 70. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 71. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 72. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 73. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 74. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 75. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 76. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 77. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 78. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 79. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2027 (USD BILLION)
TABLE 80. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 81. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 82. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 83. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 84. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 85. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 86. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 87. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 88. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 89. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 90. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 91. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 92. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 93. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 94. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 95. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 96. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 97. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 98. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 99. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 100. INDONESIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 101. INDONESIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 102. INDONESIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 103. INDONESIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 104. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 105. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 106. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 107. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 108. MALAYSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 109. MALAYSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 110. MALAYSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 111. MALAYSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 112. PHILIPPINES MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 113. PHILIPPINES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 114. PHILIPPINES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 115. PHILIPPINES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 116. SINGAPORE MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 117. SINGAPORE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 118. SINGAPORE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 119. SINGAPORE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 120. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 121. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 122. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 123. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 124. TAIWAN MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 125. TAIWAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 126. TAIWAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 127. TAIWAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 128. THAILAND MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 129. THAILAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 130. THAILAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 131. THAILAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 132. VIETNAM MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 133. VIETNAM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 134. VIETNAM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 135. VIETNAM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 141. DENMARK MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 142. DENMARK MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 143. DENMARK MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 144. DENMARK MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 145. EGYPT MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 146. EGYPT MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 147. EGYPT MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 148. EGYPT MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 149. FINLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 150. FINLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 151. FINLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 152. FINLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 153. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 154. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 155. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 156. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 157. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 158. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 159. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 160. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 161. ISRAEL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 162. ISRAEL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 163. ISRAEL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 164. ISRAEL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 165. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 166. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 167. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 168. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 169. NETHERLANDS MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 170. NETHERLANDS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 171. NETHERLANDS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 172. NETHERLANDS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 173. NIGERIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 174. NIGERIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 175. NIGERIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 176. NIGERIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 177. NORWAY MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 178. NORWAY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 179. NORWAY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 180. NORWAY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 181. POLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 182. POLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 183. POLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 184. POLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 185. QATAR MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 186. QATAR MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 187. QATAR MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 188. QATAR MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 189. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 190. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 191. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 192. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 193. SAUDI ARABIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 194. SAUDI ARABIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 195. SAUDI ARABIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 196. SAUDI ARABIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 197. SOUTH AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 198. SOUTH AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 199. SOUTH AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 200. SOUTH AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 201. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 202. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 203. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 204. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 205. SWEDEN MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 206. SWEDEN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 207. SWEDEN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 208. SWEDEN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 209. SWITZERLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 210. SWITZERLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 211. SWITZERLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 212. SWITZERLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 213. TURKEY MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 214. TURKEY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 215. TURKEY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 216. TURKEY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 217. UNITED ARAB EMIRATES MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 218. UNITED ARAB EMIRATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 219. UNITED ARAB EMIRATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 220. UNITED ARAB EMIRATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 221. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 222. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 223. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2027 (USD BILLION)
TABLE 224. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2027 (USD BILLION)
TABLE 225. GLOBAL MENS HEALTH DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 226. GLOBAL MENS HEALTH DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 227. GLOBAL MENS HEALTH DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 228. GLOBAL MENS HEALTH DIAGNOSTICS MARKET RANKING, BY KEY PLAYER, 2021
TABLE 229. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 230. GLOBAL MENS HEALTH DIAGNOSTICS MARKET MERGER & ACQUISITION
TABLE 231. GLOBAL MENS HEALTH DIAGNOSTICS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 232. GLOBAL MENS HEALTH DIAGNOSTICS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 233. GLOBAL MENS HEALTH DIAGNOSTICS MARKET INVESTMENT & FUNDING
TABLE 234. GLOBAL MENS HEALTH DIAGNOSTICS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 235. GLOBAL MENS HEALTH DIAGNOSTICS MARKET: LICENSE & PRICING

Companies Mentioned

  • Access Pharmaceuticals, Inc.
  • Advanz Pharma
  • ASKA Pharmaceutical Co.
  • Aurobindo Pharma
  • Boston Scientific
  • CordexPharma, Inc.
  • Eli Lilly and Company
  • Intas Pharmaceuticals Ltd.
  • Pantarhei Bioscience BV
  • Pfizer
  • Teva Pharmaceuticals
  • Trophogen, Inc.
  • ZydusCadila Healthcare Ltd.

Methodology

Loading
LOADING...